Saint Francis Hospital and Medical Center
About Us Programs & Services
Programs and Services A-Z Click to view list on separate page
Patients & Visitors Find a Physician
Find a Physician
Classes & Events Health Library
Health Library
Health Library Home Page Health Library Home page
Thousands of articles on health conditions, tests and procedures including videos, animations, risk assessments, quizzes and more...
Drug Search Drug Search
A comprehensive drug reference on 33,000 prescription medications, over-the-counter products, and nutraceuticals.
Adult Health Library Diseases and Conditions
From allergies to travel medicine, find detailed information on a wide range of health conditions, illnesses, and treatments.
Animations Tools and Multimedia
Animations, Videos, Calculators, Quizzes and Risk Assessments
Tests & Procedures Tests & Procedures
Information on more than 370 topics, featuring illustrations designed to clarify complex anatomy and procedures.
Nutrition Facts Search
Enter a keyword or select a letter of the alphabet to find just what you are looking for plus a lot more.
Medical Staff Education & Research Careers



Future Trends in Cardiac Surgery

Exciting new technologies on the cardiac surgical horizon at Saint Francis Hospital and Medical Center:

  1. Hybrid Coronary Revascularization: Cardiologists and cardiac surgeons working collaboratively to offer patients the best advantages of stenting and coronary bypass surgery in an integrated, minimally invasive strategy. In this approach, a robotically mediated, minimally invasive bypass of the left anterior descending coronary artery is performed using the left internal mammary artery which confers the best long-term durability of any currently available modality with a typical patency rates of this conduit of over 90% for 10- to -20 years post-operatively. This is performed without a median sternotomy and without cardiopulmonary bypass. Shortly thereafter, the patient undergoes stenting of either the right or circumflex coronary arteries. Such an approach permits the patient to have a short post – operative convalescence and excellent long-term outcomes using both minimally invasive surgical and stenting techniques. Within the very near future, the entire procedure will be able to be carried out in one session, instead of the current staged approach, in dedicated hybrid ORs, incorporating the full surgical capabilities of an operating room and the full imaging and interventional capabilities of the cath lab. New anastamotic devices will permit the surgeon to attach the bypass grafts to the target vessels on the heart more rapidly and hopefully more accurately than is possible via the conventional hand sawn techniques.

  2. Percutaneous Valve Replacement Technology: An emerging technology that will most likely result in a substantial paradigm shift to the approach of valvular pathology, a percutaneous, rather than surgical approach to aortic valve replacement and mitral valve repair. These technologies are currently undergoing clinical trials and if successful, should be available clinically in the next 3-5 years. St Francis is actively preparing for this technology by developing teams of cardiologists and cardiac surgeons proficient in these techniques and building new Hybrid ORs that will facilitate this exciting emerging technology in our community.

  3. Heart Assist Devices and Comprehensive Congestive Heart Failure Program: Saint Francis Hospital has always been a leader in the management of congestive heart failure. Unfortunately, because of the substantial discrepancy between demand and supply of heart transplants, mechanical devices are increasingly utilized to support the failing heart on a long-term basis. In collaboration with Massachusetts General Hospital, Saint Francis is embarking upon a state-of-the-art heart-assist device program allowing for both bridging to transplantation and long-term destination therapy in which the patient will have a permanent heart-assist device implanted. In addition, we are implementing a multi-disciplinary shock team to comprehensively address patients presenting to the hospital in shock. In these cases, an expeditious approach is mandatory in quickly incorporating aggressive pharmacologic management with judicious implantation of heart assist devices to address these critically ill patients and impact their high mortality rates.



The Hoffman Heart and Vascular Institute of Connecticut
114 Woodland Street
Hartford, CT 06105